| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Co-founder
3 companies
Digiandomenico Anthony is a Director at ENDRA Life Sciences Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 12 buys and 0 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | MDBH Mdb Capital Holdings, LLC | Co-founder | Buy | 355 | $6.25 | $2,218.75 | +0.4% | +1.8% | -46.5% | |
| Dec 19, 2024 | MDBH Mdb Capital Holdings, LLC | Co-founder | Buy | 3,693 | $6.22 | $22,953.53 | +1.6% | +4.5% | -45.4% | |
| May 2, 2023 | NDRA Endra Life Sciences Inc. | Director | Buy | 83,333 | $1.20 | $99,999.60 | +436.3% | -27.1% | -83.1% | |
| Jun 8, 2020 | NDRA Endra Life Sciences Inc. | Director | Buy | 5,000 | $0.92 | $4,600.00 | +1.8% | - | - | |
| May 28, 2020 | NDRA Endra Life Sciences Inc. | Director | Buy | 5,000 | $0.90 | $4,500.00 | +1.8% | - | - | |
| May 22, 2020 | NDRA Endra Life Sciences Inc. | Director | Buy | 10,000 | $0.78 | $7,800.00 | +4.1% | - | - | |
| Dec 28, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 7,000 | $4.62 | $32,340.00 | +14.0% | - | - | |
| Dec 27, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 20,000 | $4.77 | $95,400.00 | +66.7% | - | - | |
| Dec 24, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 10,000 | $4.81 | $48,100.00 | +50.0% | - | - | |
| Dec 21, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 10,000 | $4.49 | $44,900.00 | +100.0% | - | - |